Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Neurogenic Inflammation

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Neurogenic Inflammation in 2 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Neurogenic Inflammation: Inflammation caused by an injurious stimulus of peripheral neurons and resulting in release of neuropeptides which affect vascular permeability and help initiate proinflammatory and immune reactions at the site of injury.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Javed, H1
Thangavel, R1
Selvakumar, GP1
Dubova, I1
Schwartz, N1
Ahmed, ME1
Zaheer, S1
Kempuraj, D1
Iyer, S1
Zaheer, A1
Khan, MM1
Wi, R1
Chung, YC1
Jin, BK1

Other Studies

2 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Neurogenic Inflammation

ArticleYear
NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    International immunopharmacology, 2020, Volume: 83

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cells, Cultured; Disease Models, A

2020
Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease.
    Journal of immunology research, 2020, Volume: 2020

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Capsaicin; Disease Models, Animal; Dopaminerg

2020